Tauriga Sciences, Inc.
Tauriga Sciences Inc. Actively Evaluating Potential Acquisition Targets to Restore and Create Lasting Shareholder Value
03 sept. 2013 08h08 HE | Tauriga Sciences Inc
LOS ANGELES, Sept. 3, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
Tauriga Sciences, Inc.
Tauriga Sciences Inc. Fully Satisfies Exclusive 5 Year License Agreement With Green Hygienics, Inc. for the Commercialization of 100% Tree-Free, Bamboo-Based Products to the North American Marketplace
29 août 2013 08h03 HE | Tauriga Sciences Inc
LOS ANGELES, Aug. 29, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified life sciences company focused on investing in proprietary biotherapeutics...
Tauriga Sciences, Inc.
Tauriga Sciences Inc. Granted 30 Day Extension to Fully Satisfy Terms and Conditions of 5 Year Exclusive License Agreement With Green Innovations Ltd.
02 août 2013 12h06 HE | Tauriga Sciences Inc
NEW YORK, Aug. 2, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified life sciences company focused on investing in proprietary biotherapeutics and...
Tauriga Sciences, Inc.
Tauriga Sciences Inc. Announces Effectiveness of Registration Statement (Form S1) Filed Pursuant to $5,000,000 USD Stock Purchase Agreement With Magna Group
01 août 2013 09h05 HE | Tauriga Sciences Inc
NEW YORK, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) (the "Company"), a diversified life sciences company focused on investing in proprietary biotherapeutics and diagnostics,...
Tauriga Sciences, Inc.
Tauriga Sciences Appoints ProActive Capital Group as Capital Markets & Digital Media Advisor
25 juil. 2013 08h05 HE | Tauriga Sciences Inc
NEW YORK, July 25, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG), a diversified life sciences company focused on proprietary biotherapeutics and diagnostics, novel medical devices and...
Tauriga Sciences, Inc.
Tauriga Sciences Inc. Licensor Soon to Offer Class 100,000 ISO 8 Critical Environment Applications for the Medical Industry
18 juil. 2013 09h49 HE | Tauriga Sciences Inc
NEW YORK, July 18, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG), a diversified life sciences company focused on proprietary biotherapeutics and diagnostics, novel medical devices and...
Tauriga Sciences, Inc.
Tauriga Sciences, Inc. Anticipates That Green Hygienics' Bamboo-Based 100% Tree-Free Medical Products to be Available for Commercial Marketplace Before the End of the Current Quarter
08 juil. 2013 15h12 HE | Tauriga Sciences Inc
LOS ANGELES, July 8, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified life sciences company focused on proprietary biotherapeutics and...
Tauriga Sciences, Inc.
Tauriga Sciences Inc. Fully Repays $150,000 Payment on Convertible Promissory Note
28 juin 2013 08h00 HE | Tauriga Sciences Inc
LOS ANGELES, June 28, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified life sciences company focused on proprietary biotherapeutics and...
Tauriga Sciences, Inc.
Tauriga Sciences, Inc. to Commence Presentations to Key Distribution Groups in the Southeast United States for the Conversion to "100% Tree-Free" Biodegradable Products to the Hospitals They Supply
17 juin 2013 08h00 HE | Tauriga Sciences Inc
SAN FRANCISCO, June 17, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified life sciences company focused on investing in proprietary...
Tauriga Sciences, Inc.
Tauriga Sciences Inc. Completes $5 Million Stock Purchase Agreement With New York Based Institutional Investor Magna Group Through Flagship Equity Enhancement Program
05 juin 2013 08h02 HE | Tauriga Sciences Inc
NEW YORK, June 5, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified life sciences company focused on investing in proprietary biotherapeutics and...